Overview
Bexarotene (Targretin) is an antineoplastic agent indicated by the FDA for Cutaneous T cell lymphoma. It has been used off-label for lung cancer, breast cancer, and Kaposi's sarcoma.
Indication
用于全身治疗无效的皮肤Ｔ细胞淋巴癌（CTCL）。
Associated Conditions
- Refractory Cutaneous T-cell Lymphoma
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2022/03/25 | Phase 1 | Recruiting | |||
2021/11/03 | Not Applicable | Withdrawn | |||
2020/12/11 | Phase 1 | Recruiting | National Cancer Centre, Singapore | ||
2017/10/27 | Phase 1 | Completed | |||
2014/02/13 | Phase 1 | Completed | |||
2013/02/04 | Phase 2 | Completed | |||
2012/04/17 | Phase 3 | Completed | |||
2010/06/02 | Phase 1 | Completed | |||
2010/05/05 | Phase 1 | Completed | |||
2009/11/04 | Phase 4 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Actavis Pharma, Inc. | 0591-2832 | ORAL | 75 mg in 1 1 | 11/11/2021 | |
| Bausch Health US, LLC | 0187-5525 | TOPICAL | 1 g in 100 g | 2/3/2020 | |
| Hikma Pharmaceuticals USA Inc. | 0054-0399 | ORAL | 75 mg in 1 1 | 11/11/2020 | |
| Oceanside Pharmaceuticals | 68682-003 | ORAL | 75 mg in 1 1 | 4/4/2020 | |
| Amneal Pharmaceuticals NY LLC | 69238-2088 | TOPICAL | 10 mg in 1 g | 12/29/2023 | |
| ANI Pharmaceuticals, Inc. | 43975-315 | ORAL | 75 mg in 1 1 | 9/30/2020 | |
| Bausch Health US, LLC | 0187-5526 | ORAL | 75 mg in 1 1 | 4/30/2020 | |
| Upsher-Smith Laboratories, Inc. | 0832-0285 | ORAL | 75 mg in 1 1 | 6/1/2017 | |
| Mylan Pharmaceuticals Inc. | 0378-6955 | ORAL | 75 mg in 1 1 | 6/14/2017 | |
| AvKARE | 42291-072 | ORAL | 75 mg in 1 1 | 4/14/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
H.A.C. Pharma,Pericentre 2,43 Avenue De La Cote De Nacre,Caen,14000,France | Authorised | 3/29/2001 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.